H. BEYAZAL POLAT Et Al. , "Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19," European Journal of Clinical and Experimental Medicine , vol.22, 2024
BEYAZAL POLAT, H. Et Al. 2024. Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19. European Journal of Clinical and Experimental Medicine , vol.22 .
BEYAZAL POLAT, H., ARPA, M., POLAT, Z., BEYAZAL, M., BEYAZAL ÇELİKER, F., AYAZ, T., ... ERTÜRK, A.(2024). Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19. European Journal of Clinical and Experimental Medicine , vol.22.
BEYAZAL POLAT, HATİCE Et Al. "Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19," European Journal of Clinical and Experimental Medicine , vol.22, 2024
BEYAZAL POLAT, HATİCE B. Et Al. "Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19." European Journal of Clinical and Experimental Medicine , vol.22, 2024
BEYAZAL POLAT, H. Et Al. (2024) . "Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19." European Journal of Clinical and Experimental Medicine , vol.22.
@article{article, author={HATİCE BEYAZAL POLAT Et Al. }, title={Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19}, journal={European Journal of Clinical and Experimental Medicine}, year=2024}